Veterinary Renal Disease Market Size, Share & Trends Analysis Report By Type, By Animal Type (Canine, Feline, Bovine, Equine, Others), By Route of Administration, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Veterinary Renal Disease Market Trends

The global veterinary renal diseases market size was valued at USD 15.66 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.49% from 2024 to 2030. The market is driven by rising prevalence of renal complications in animals, prominent usage of pet food for renal disease treatment, incidence of renal stones and cystitis among animals, and disease awareness initiatives. Rising diagnosis aided by increasing usage of blood work and imaging techniques is further expected to fuel market growth. To evaluate kidney function in animals, veterinarians use blood testing and urine analysis (urinalysis) to determine the concentrations of waste products and other components that healthy kidneys usually filter or manage. Additional investigations that may help assess an animal with possible renal problems include radiography (X-rays), abdominal ultrasounds, and, in certain situations, microscopic analysis of biopsy samples.

It has been reported that there has been a high prevalence of renal stones among the animals. According to a 2022 study published in PubMed Central, it was estimated to be 9.5% and 24.0% in dogs  and cats. Also, another Sage Journal Study inferred that bacterial cystitis was documented in 65% of cats. This high prevalence provides lucrative growth opportunities to the market.

Industry leaders like Mars Inc., Nestle Purina PetCare, Hills Pet Nutrition, J.M.Smucker, Zoetis Inc., Merck & Co., Inc., IDEXX Laboratories, Inc., etc. are adopting strategies, such as launch of new products, partnerships, and mergers and acquisitions in order to gain a greater share of the market.

Globally, there has been a high prevalence of Chronic Kidney Disease (CKD) in companion animals like dogs and cats. As per the data published by MSD Veterinary Manual in October 2022, the disease often develops for many months or years before it becomes clinically apparent and is invariably irreversible and frequently progressive. It is more common in animals who are 5 to 6 years of age. Globally, up to 10% of dogs and 35% of cats are affected by CKD. The prevalence of small animals in a general population may be estimated to be less than 1%, or 3%. Moreover, as  per the International Renal Interest society, prevalence of chronic kidney disease (CKD) has been estimated to be 0.5-1.0% in dogs and 1.0-3.0% in cats, but it increases with age, especially in cats with reported prevalence of 80% in the geriatric cat population.

A 2021 study published in LUVAS India, explored the prevalence of Urinary Tract Infection (UTI) in Indian cattle. As per the findings prevalence acute and chronic cystitis was found out to be 18.64% and 31.35% respectively. A 2019 study published by Journal of Veterinary Internal Medicine inferred that prevalence of AKI (Acute Kidney Injury) was estimated to be 14.8%.      

All these factors collectively contribute to increasing the need for proper and timely diagnosis and treatment of these renal complications. Which is effectively driving the market to a positive growth outlook.

Market Concentration & Characteristics

Market players are involved in consolidation activities such as M&A to expand their geographical foothold, across countries, and build on existing resources & capabilities to meet the high demand. This allows market players to leverage existing expertise, technology, or labor at a wider scale and serve more customers.

The market is also characterized by a strategy to partner with other counterparts in the industry to boost their market position & revenue. These initiatives may be implemented to expand regionally or widen global network to reach more customers. For instance, in January 2023, Purina Pro Plan Veterinary Diets announced partnership with American Veterinary Medical Foundation (AVMF) to help expand their Reaching Every Animal with Charitable Care (REACH) program, which offers grants to veterinarians who provide immediate care for owners experiencing financial hardship. For each purchase made on Purina Pro Plan's VetDirect website from January 15, 2023 through June 30, 2023, Purina donated $1 to the AVMF to support the REACH program, up to $200,000.

Moreover, in February 2023, Mars Petcare acquired Champion Petfoods, with a view to complement the company's global portfolio across pet nutrition products and health services. Champion Petfoods will operate as an independent business unit within Mars Pet Nutrition.

The market for veterinary kidney diseases has experienced notable changes due to a multitude of variables. The degree of innovation has been crucial, as improvements in therapy and diagnostic technology have improved the overall effectiveness of managing renal illness in animals. The volume of merger and acquisition activity has also influenced market dynamics by forming strategic partnerships that have aided in R&D projects and extended the market reach of major companies.

Regulations have had a significant influence; that shaped marketing plans and product development. The emergence of safer and more effective medicines for veterinary renal disorders has been impacted by strict regulatory regulations. The market rivalry has been impacted by the existence of effective alternatives to treatments for renal disease, which has forced businesses to innovate and distinguish their goods in order to stay ahead of the competition.

The market landscape has been impacted by regional expansion, as companies aim to penetrate new markets to take advantage of new opportunities and satisfy the increasing demand for veterinary renal disease solutions. The intricate interactions between innovation, M&A, legislation, replacements, and regional expansion shape the dynamic veterinary renal disorders industry, as these aspects collectively demonstrate.

The market is price-sensitive, and companies are involved in offering customers the right balance of quality and affordability to increase sales. Although established manufacturers such as Mars Inc., Nestle Purina PetCare, Hills Pet Nutrition, J.M.Smucker, Zoetis Inc., Merck & Co., Inc., IDEXX Laboratories, Inc. have a strong customer base and portfolio, the emergence of new and niche players poses significant competition. The availability of cheaper alternatives from manufacturers and traders in countries including China & India increases competition with existing market players.

Currently, a large number of drugs used for drugs used in renal disease treatment in veterinary if “off-label” or “extra-label.” As in, veterinarians are prescribing drugs that are approved by regulatory authorities for specific disease, for use in other indications. For example, Thiola (Travere Therapeutics ), is a normally used in kidney stones as a cystine-binding agent in humans. But, at prescription of veterinarian, in some cases it is administered “off-label” to dogs for prevention of kidney stones. Such use a can prove to be harmful for animal if not monitored accurately. Therefore, “Off-label” use of drugs in veterinary treatment can prove to be challenging and may hamper the market growth.

Type Insights

Treatment segment held highest market share of over 65.00% in 2023. This is explained by the rising incidence of kidney disorders in animals, which has raised the need for efficient treatment solutions. The need for treatment measures to control and alleviate renal ailments in animals is increasing as more animals receive such diagnoses. Furthermore, developments in veterinary medicine have led to the creation of a wide range of therapeutic goods that address different elements of renal illnesses. These products include pharmaceuticals, therapeutic pet diets, ringer lactate solution, etc.

Veterinarians now have a wider tool to address various stages and kinds of renal problems in animals thanks to this assortment of therapeutic options. Furthermore, veterinary clinics' emphasis on proactive and preventative healthcare highlights the significance of treatment products. Treatment dominates the market because veterinarians and pet owners are choosing more and more complete treatment strategies to enhance the general health of animals with kidney conditions.

Among Treatment, therapeutic food supplements has taken highest share in 2023. This is due to dynamic nature of this segment. By meeting certain dietary needs, tailored renal diets and supplements play a crucial role in supporting kidney function. These goods are made to control essential elements like protein and phosphorus, which are vital for lessening the strain on the kidneys. The inclination towards therapeutic food supplements can also be ascribed to their convenience of administration, which guarantees better adherence from pet owners. These supplements' dominance in the market can be attributed to their holistic and preventive approach, which they provide as essential components of comprehensive treatment schemes.

Animal Type Insights

By Animal type, feline segment held highest market share of over 47.0% in 2023. This is due to relatively higher occurrence of renal diseases among cats. Due to factors which includes their specific anatomy, breed vulnerability, and a higher incidence of conditions like chronic kidney disease, cats tend to have a higher prevalence of renal diseases. Age-related degeneration of the feline kidney is common, and certain breeds may be genetically predisposed to kidney problems. Cats may also tend to hide their symptoms, which could delay diagnosis. All these elements work together to cause cats to have the highest percentage of veterinary renal illnesses among the dog, horse, and cow animal types. As per 2021 data published by AVMA, Chronic Kidney Disease (CKD) in cats can be ranged between 2% - 20%. For cats older than 10 - 15 years, this number can rise up to 30% - 80%. Cats are estimated to have highest prevalence of renal complications among all other animals.

Feline segment is followed by canine segment in terms of market share in 2023 as a result of elements like their sensitivity to genetic predispositions unique to their breed, exposure to environmental variables, etc. The incidence is partly explained by the higher propensity of certain dog breeds to acquire renal problems. Like cats, dogs can often have mild signs that take longer to diagnose. Although renal illnesses are less common in equine and bovine species, dogs are the second most affected group in the veterinary setting due to a combination of genetic factors and environmental impacts. Furthermore, higher detection and diagnosis of renal disorders in dogs have resulted from advances in veterinary diagnostics and expanding pet owner understanding, etc.

Route of Administration Insights

By route of administration, oral segment held highest market share in 2023. This is largely owed to high adoption of therapeutic food supplements. When it comes to giving medications to animals, oral administration is usually less stressful and more convenient than injectable techniques. This ease of use is also important for maintaining long-term drug adherence, such as in the case of renal illnesses, which are chronic ailments.

Better bioavailability is frequently provided by oral treatments, guaranteeing that the pharmaceuticals are efficiently absorbed and dispersed throughout the body, including the renal system. Additionally, kidney function is supported, symptoms are managed, and the advancement of renal disorders is slowed down with specially prepared renal meals for animals. To lessen the strain on the kidneys, these therapeutic diets frequently include restricted amounts of important nutrients like protein and phosphorus.

Indication Insights

By indication, renal cystitis segment held highest market share of over 29.0% in 2023. Cystitis is an inflammation of urinary bladder. About 12% of healthy dogs and 30% of dogs with comorbidities like diabetes mellitus suffer from renal cystitis. This infection can further lead to complications in the kidney and lead to pyelonephritis. Renal cystitis, or inflamed bladder, is frequently linked to bacterial infections that can travel up from the lower urinary system and impact the kidneys. In dogs, cats, and other animals, this ailment is rather prevalent.

Renal cystitis may present with more pronounced symptoms than other indications such chronic kidney disease (CKD) or renal failure, which may lead pet owners to seek veterinarian care early in the course of the disease. Furthermore, antibiotics are an effective treatment for renal cystitis, which results in a reasonably high diagnostic and good management rate. Moreover, renal cystitis is a more common and identifiable indication because it can occasionally occur with or ahead of other renal diseases. Therefore rise rising prevalence of renal cystitis has been identified as major factor promoting market growth.

Distribution Channel Insights

Veterinary Hospitals & Clinics segment dominated market with a share of over 43.0% in 2023. The primary facilities where pet owners go for expert medical advice and treatment for their animals are veterinary hospitals and clinics. These facilities are crucial for providing complete veterinary care since renal illnesses frequently need for diagnosis, continuous management, and monitoring. Additionally, veterinary clinics and hospitals are well-equipped with diagnostic equipment and services, such as imaging and laboratory testing, that allow for an accurate assessment of kidney health. This infrastructure makes it easier to diagnose kidney disorders quickly and accurately, which enables rapid intervention and treatment.

Almost all products, including veterinary renal disease, have been affected by changing customer behavior, in particular shift towards online shopping as a result of COVID-19 pandemic and digitalisation. The fact that retailers have carried out fewer sales of goods and pharmaceuticals than they have done in the past is widely acknowledged and often referred to. For example, in general, a high proportion of pet owners buy drugs, specialty foods and other therapeutic foods at a physical store for dogs, cats and other pets. The growth of market is largely due to a number of e-commerce websites. There is a growing demand for easy access to pet renal care products due to an increasing number of families that have companion animals.

Regional Insights

North America veterinary renal diseases market held largest share of 40.20% of the global market in 2023, A significant driver of growth in market has been pointed out to be growing importance of overall animal health care across the region. According to the American Pet Products Association, there were 65.1 million households in United States with a pet in 2023-24. Moreover, the growth of veterinary renal disease market in North America is being driven by increased pet owners' knowledge about animal health and increasing importance to care for animals with renal diseases.

Pet owners have significant amounts of disposable cash, a strong veterinary healthcare infrastructure, and established regulatory frameworks. The market in the region is developed and sophisticated, with a strong emphasis on pet preventative care, which has increased the need for veterinary goods and services.

Asia Pacific is anticipated to witness significant growth in the veterinary renal diseases market. Pet owners are becoming more aware of need of preserving their pets’ overall health. Almost all technological advances in field of animal health are being driven by East Asia. Ideal environment for leading healthcare companies to expand their business has been created by increasing awareness of importance of animal health, coupled with growing pet ownership in China and Japan. Boehringer Ingelheim, for instance, acquired equity in China-based New Ruipeng Group (NRP Group) in September 2020.

In recent years, there has been an increase in number of pet families in India, indicating a strong desire to adopt a pet. The constrained lifestyle and move to WFH (work from home) has had an influence on mental health during the COVID-19 pandemic. In such a case, pet adoptions are expected to increase mainly in order to provide psychological support and assistance.

This growing trend has led to the adoption of dogs in India by their customers, who are treating them as family pets. There are over 6,00,000 dogs being fostered each year, and other factors contributing to increase in adoptions include nuclear families, retired people, or children's emotional bonds.

Key Veterinary Renal Disease Company Insights

Some of the key players operating in market include Mars Inc., Nestle Purina PetCare, Hills Pet Nutrition, J.M.Smucker, Zoetis Inc., Merck & Co., Inc., IDEXX Laboratories, Inc., etc.

VetPharma, Vedco Inc., Mission Pharmacal Company, Rayne Clinical Nutrition, Neogen Corporation, Roquette Frères, etc. are some of the emerging market participants in veterinary renal diseases market.

Market participants are actively involved in an array of strategies that improve their market presence. Innovative products, including enhanced diagnostics and treatment options, are constantly being introduced by companies to cater to the changing demands of pet owners and veterinarians. Collaborations and partnerships with academic institutions and other companies frequently occur, encouraging exchange of knowledge and expediting the development of unique solutions. In order to take advantage of fresh opportunities and increase the size of the client base, ongoing expansion strategies involve entering new geographic areas.

There are numerous instances of merger and acquisition activities going on, and businesses are seeking strategic alliances in order to expand their current offerings, acquire new technology, and gain market share. Players in the market are clearly making constant efforts to be at the forefront of veterinary renal disease management through research and development. Collectively, these multiple strategies add to the veterinary renal disorders market's dynamic and competitive landscape.

Recent Developments

• In January 2024, Zoetis Inc., announced expansion of its multi-application diagnostics platform, Vetscan Imagyst, to include AI Urine Sediment analysis. The new application will enable accurate, in-clinic sediment analysis of fresh urine, allowing clinicians to make treatment decisions quickly. Powered by deep learning artificial intelligence (AI), Vetscan Imagyst AI Urine Sediment analysis offers veterinarians consistent, accurate results within minutes.

• In June 2023 , IDEXX Laboratories, Inc. launched  its first veterinary diagnostic test for detecting kidney injury in cats and dogs. The IDEXX Cystatin B Test will be included in test panels assessing renal health and will be run at IDEXX Reference Laboratories in the U.S. and Canada, with plans to introduce test in Europe in 2024.

• In Feb 2023, Nestlé Purina PetCare Company voluntarily recalled select lots of Purina Pro Plan Veterinary Diets EL Elemental (PPVD EL) prescription dry dog food due to potentially elevated levels of vitamin D. Vitamin D is an essential nutrient for dogs; however, ingestion of elevated levels can lead to health issues depending on the level of vitamin D and the length of exposure. Vitamin D toxicity may include vomiting, loss of appetite, increased thirst, increased urination, and excessive drooling to renal (kidney) dysfunction.

• In October 2023, Hill's Pet Nutrition, a division of Colgate-Palmolive opened its newest manufacturing plant in Tonganoxie, Kan. Located on more than 80 acres, the 365,000 square foot, fully designed smart facility will increase company's production capacity for canned pet food and provide a runway for continued expansion of Hill's Science Diet and Prescription Diet brand

Veterinary Renal Diseases Market Report Scope

Global Veterinary Renal Diseases Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global veterinary renal disease market report based on type, animal type, route of administration, indication, distribution channel, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Diagnosis

    • Test Kits & Consumables

    • Instruments

  • Treatment

    • Drugs

      • NSAIDs

      • Antibiotics

      • Cystine-binding Agents

      • Diuretics

      • Others

    • Therapeutic Food Supplements

    • Ringer Lactate Solution

• Animal type Outlook (Revenue, USD Million, 2018 - 2030)

  • Canine

  • Feline

  • Bovine

  • Equine

  • Others

• Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

  • Oral

  • Injectable

• Indication Outlook (Revenue, USD Million, 2018 - 2030)

  • Renal Failure

  • Chronic Kidney Disease (CKD)

  • Renal Cystitis

  • Kidney Stones

  • Nephritis

  • Others

• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Veterinary Hospitals & Clinics

  • Pet Specialty Stores

  • E-Commerce

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait